Erlotinib enhances the proapoptotic activity of cytotoxic agents and synergizes with paclitaxel in poorly-differentiated thyroid carcinoma cells

MLA

Matteo, Landriscina, et al. “Erlotinib Enhances the Proapoptotic Activity of Cytotoxic Agents and Synergizes with Paclitaxel in Poorly-Differentiated Thyroid Carcinoma Cells.” Anticancer Research, vol. 30, no. 2, Mar. 2010. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........efa5ac94ba0d6f2be60495036683bc9f&authtype=sso&custid=ns315887.

APA

Matteo, L., Francesca, M., Annarita, F., Annamaria, P., Olga, L. M., & Mauro, C. (2010). Erlotinib enhances the proapoptotic activity of cytotoxic agents and synergizes with paclitaxel in poorly-differentiated thyroid carcinoma cells. Anticancer Research, 30(2).

Chicago

Matteo, Landriscina, Maddalena Francesca, Fabiano Annarita, Piscazzi Annamaria, La Macchia Olga, and Cignarelli Mauro. 2010. “Erlotinib Enhances the Proapoptotic Activity of Cytotoxic Agents and Synergizes with Paclitaxel in Poorly-Differentiated Thyroid Carcinoma Cells.” Anticancer Research 30 (2). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........efa5ac94ba0d6f2be60495036683bc9f&authtype=sso&custid=ns315887.